# Decision Support System for Chronic Diseases Based on Drug-Drug Interactions

arXiv: https://arxiv.org/abs/2303.02405 · HTML: https://mlsanity.com/paper/2303.02405/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 23 of its 59 references that are in the map.
- First posted on arXiv 4 Mar 2023.

## Builds on (most cited first, 23 of 23)

- [Adam: A Method for Stochastic Optimization](https://mlsanity.com/paper/1412.6980/) (2014)
- [Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift](https://mlsanity.com/paper/1502.03167/) (2015)
- [How Powerful are Graph Neural Networks?](https://mlsanity.com/paper/1810.00826/) (2018)
- [A Comprehensive Survey on Graph Neural Networks](https://mlsanity.com/paper/1901.00596/) (2019)
- [Empirical Evaluation of Gated Recurrent Neural Networks on Sequence Modeling](https://mlsanity.com/paper/1412.3555/) (2014)
- [LightGCN: Simplifying and Powering Graph Convolution Network for Recommendation](https://mlsanity.com/paper/2002.02126/) (2020)
- [DKN: Deep Knowledge-Aware Network for News Recommendation](https://mlsanity.com/paper/1801.08284/) (2018)
- [Generative Causal Explanations for Graph Neural Networks](https://mlsanity.com/paper/2104.06643/) (2021)
- [Distilling Causal Effect of Data in Class-Incremental Learning](https://mlsanity.com/paper/2103.01737/) (2021)
- [Size-Invariant Graph Representations for Graph Classification Extrapolations](https://mlsanity.com/paper/2103.05045/) (2021)
- [Deconfounded Video Moment Retrieval with Causal Intervention](https://mlsanity.com/paper/2106.01534/) (2021)
- [Learning from Counterfactual Links for Link Prediction](https://mlsanity.com/paper/2106.02172/) (2021)
- [Signed Graph Attention Networks](https://mlsanity.com/paper/1906.10958/) (2019)
- [SafeDrug: Dual Molecular Graph Encoders for Recommending Effective and Safe Drug Combinations](https://mlsanity.com/paper/2105.02711/) (2021)
- [Pixie: A System for Recommending 3+ Billion Items to 200+ Million Users in Real-Time](https://mlsanity.com/paper/1711.07601/) (2017)
- [CauseRec: Counterfactual User Sequence Synthesis for Sequential Recommendation](https://mlsanity.com/paper/2109.05261/) (2021)
- [GoGNN: Graph of Graphs Neural Network for Predicting Structured Entity Interactions](https://mlsanity.com/paper/2005.05537/) (2020)
- [Should Graph Convolution Trust Neighbors? A Simple Causal Inference Method](https://mlsanity.com/paper/2010.11797/) (2020)
- [Deconvolutional Networks on Graph Data](https://mlsanity.com/paper/2110.15528/) (2021)
- [Knowledge Graph Completion with Counterfactual Augmentation](https://mlsanity.com/paper/2302.13083/) (2023)
- [Graph Autoencoders with Deconvolutional Networks](https://mlsanity.com/paper/2012.11898/) (2020)
- [Approximate Closest Community Search in Networks](https://mlsanity.com/paper/1505.05956/) (2015)
- [Syndrome-aware Herb Recommendation with Multi-Graph Convolution Network](https://mlsanity.com/paper/2002.08575/) (2020)

## Abstract (arXiv)

Many patients with chronic diseases resort to multiple medications to relieve various symptoms, which raises concerns about the safety of multiple medication use, as severe drug-drug antagonism can lead to serious adverse effects or even death. This paper presents a Decision Support System, called DSSDDI, based on drug-drug interactions to support doctors prescribing decisions. DSSDDI contains three modules, Drug-Drug Interaction (DDI) module, Medical Decision (MD) module and Medical Support (MS) module. The DDI module learns safer and more effective drug representations from the drug-drug interactions. To capture the potential causal relationship between DDI and medication use, the MD module considers the representations of patients and drugs as context, DDI and patients' similarity as treatment, and medication use as outcome to construct counterfactual links for the representation learning. Furthermore, the MS module provides drug candidates to doctors with explanations. Experiments on the chronic data collected from the Hong Kong Chronic Disease Study Project and a public diagnostic data MIMIC-III demonstrate that DSSDDI can be a reliable reference for doctors in terms of safety and efficiency of clinical diagnosis, with significant improvements compared to baseline methods.